404 related articles for article (PubMed ID: 30590322)
21. Roles of exosomes in metastatic colorectal cancer.
Lafitte M; Lecointre C; Roche S
Am J Physiol Cell Physiol; 2019 Nov; 317(5):C869-C880. PubMed ID: 31291143
[TBL] [Abstract][Full Text] [Related]
22. Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer.
Niu L; Song X; Wang N; Xue L; Song X; Xie L
Cancer Sci; 2019 Jan; 110(1):433-442. PubMed ID: 30407700
[TBL] [Abstract][Full Text] [Related]
23. Exosomes in tumor microenvironment: novel transporters and biomarkers.
Wang Z; Chen JQ; Liu JL; Tian L
J Transl Med; 2016 Oct; 14(1):297. PubMed ID: 27756426
[TBL] [Abstract][Full Text] [Related]
24. Recent progress in the emerging role of exosome in hepatocellular carcinoma.
Abudoureyimu M; Zhou H; Zhi Y; Wang T; Feng B; Wang R; Chu X
Cell Prolif; 2019 Mar; 52(2):e12541. PubMed ID: 30397975
[TBL] [Abstract][Full Text] [Related]
25. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer.
Zhang R; Xia Y; Wang Z; Zheng J; Chen Y; Li X; Wang Y; Ming H
Biochem Biophys Res Commun; 2017 Aug; 490(2):406-414. PubMed ID: 28623135
[TBL] [Abstract][Full Text] [Related]
26. [Advances in Exosomes in the Pathogenesis and Diagnosis of Lung Cancer].
Bi H; Ren D; Zhang J; Wang H
Zhongguo Fei Ai Za Zhi; 2020 Jul; 23(7):589-596. PubMed ID: 32702793
[TBL] [Abstract][Full Text] [Related]
27. Progress of exosomes in the diagnosis and treatment of lung cancer.
Xu K; Zhang C; Du T; Gabriel ANA; Wang X; Li X; Sun L; Wang N; Jiang X; Zhang Y
Biomed Pharmacother; 2021 Feb; 134():111111. PubMed ID: 33352449
[TBL] [Abstract][Full Text] [Related]
28. Rethinking Gamma-secretase Inhibitors for Treatment of Non-small-Cell Lung Cancer: Is Notch the Target?
Pine SR
Clin Cancer Res; 2018 Dec; 24(24):6136-6141. PubMed ID: 30104200
[TBL] [Abstract][Full Text] [Related]
29. Exosomes: Emerging modulators of signal transduction in colorectal cancer from molecular understanding to clinical application.
Bahrami A; Moradi Binabaj M; A Ferns G
Biomed Pharmacother; 2021 Sep; 141():111882. PubMed ID: 34218003
[TBL] [Abstract][Full Text] [Related]
30. Exosomes: Emerging biomarkers and targets for ovarian cancer.
Tang MK; Wong AS
Cancer Lett; 2015 Oct; 367(1):26-33. PubMed ID: 26189430
[TBL] [Abstract][Full Text] [Related]
31. Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer.
Lei Y; Guo W; Chen B; Chen L; Gong J; Li W
Oncol Rep; 2018 Dec; 40(6):3438-3446. PubMed ID: 30542738
[TBL] [Abstract][Full Text] [Related]
32. Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway.
Taverna S; Pucci M; Giallombardo M; Di Bella MA; Santarpia M; Reclusa P; Gil-Bazo I; Rolfo C; Alessandro R
Sci Rep; 2017 Jun; 7(1):3170. PubMed ID: 28600504
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological significance and potential drug target of T-cadherin in NSCLC.
Wang Z; Wang B; Guo H; Shi G; Hong X
Drug Des Devel Ther; 2015; 9():207-16. PubMed ID: 25565774
[TBL] [Abstract][Full Text] [Related]
34. Extracellular vesicles in non-small cell lung cancer stemness and clinical applications.
Pandya P; Al-Qasrawi DS; Klinge S; Justilien V
Front Immunol; 2024; 15():1369356. PubMed ID: 38765006
[TBL] [Abstract][Full Text] [Related]
35. Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.
El-Nikhely N; Larzabal L; Seeger W; Calvo A; Savai R
Expert Opin Investig Drugs; 2012 Aug; 21(8):1107-22. PubMed ID: 22667993
[TBL] [Abstract][Full Text] [Related]
36. Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer.
He J; Hu Y; Hu M; Li B
Sci Rep; 2015 Aug; 5():13110. PubMed ID: 26279307
[TBL] [Abstract][Full Text] [Related]
37. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
38. Up-regulated HMGB1 in the pleural effusion of non-small cell lung cancer (NSCLC) patients reduces the chemosensitivity of NSCLC cells.
Ma Y; Kang S; Wu X; Han B; Jin Z; Guo Z
Tumori; 2018 Oct; 104(5):338-343. PubMed ID: 28885675
[TBL] [Abstract][Full Text] [Related]
39. Multiple Roles of Exosomal Long Noncoding RNAs in Cancers.
Zhao W; Liu Y; Zhang C; Duan C
Biomed Res Int; 2019; 2019():1460572. PubMed ID: 31360701
[TBL] [Abstract][Full Text] [Related]
40. A decade of advances in treatment for advanced non-small cell lung cancer.
Gettinger S; Lynch T
Clin Chest Med; 2011 Dec; 32(4):839-51. PubMed ID: 22054890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
